Global Leiomyosarcoma Drug Market Research Report 2019

Table of Contents

Executive Summary

1 Leiomyosarcoma Drug Market Overview

• 1.1 Product Overview and Scope of Leiomyosarcoma Drug
• 1.2 Leiomyosarcoma Drug Segment by Type
  • 1.2.1 Global Leiomyosarcoma Drug Production Growth Rate Comparison by Type (2014-2025)
  • 1.2.2 AL-3818
  • 1.2.3 BGB-290
  • 1.2.4 C-21
  • 1.2.5 Others
• 1.3 Leiomyosarcoma Drug Segment by Application
  • 1.3.1 Leiomyosarcoma Drug Consumption Comparison by Application (2014-2025)
  • 1.3.2 Clinic
  • 1.3.3 Hospital
  • 1.3.4 Others
• 1.3 Global Leiomyosarcoma Drug Market by Region
  • 1.3.1 Global Leiomyosarcoma Drug Market Size Region
  • 1.3.2 North America Status and Prospect (2014-2025)
  • 1.3.3 Europe Status and Prospect (2014-2025)
  • 1.3.4 China Status and Prospect (2014-2025)
  • 1.3.5 Japan Status and Prospect (2014-2025)
  • 1.3.6 Southeast Asia Status and Prospect (2014-2025)
  • 1.3.7 India Status and Prospect (2014-2025)
• 1.4 Global Leiomyosarcoma Drug Market Size
  • 1.4.1 Global Leiomyosarcoma Drug Revenue (2014-2025)
  • 1.4.2 Global Leiomyosarcoma Drug Production (2014-2025)

2 Global Leiomyosarcoma Drug Market Competition by Manufacturers

• 2.1 Global Leiomyosarcoma Drug Production Market Share by Manufacturers (2014-2019)
• 2.2 Global Leiomyosarcoma Drug Revenue Share by Manufacturers (2014-2019)
• 2.3 Global Leiomyosarcoma Drug Average Price by Manufacturers (2014-2019)
• 2.4 Manufacturers Leiomyosarcoma Drug Production Sites, Area Served, Product Types
• 2.5 Leiomyosarcoma Drug Market Competitive Situation and Trends
  • 2.5.1 Leiomyosarcoma Drug Market Concentration Rate
  • 2.5.2 Leiomyosarcoma Drug Market Share of Top 3 and Top 5 Manufacturers
  • 2.5.3 Mergers & Acquisitions, Expansion

3 Global Leiomyosarcoma Drug Production Market Share by Regions

• 3.1 Global Leiomyosarcoma Drug Production Market Share by Regions
• 3.2 Global Leiomyosarcoma Drug Revenue Market Share by Regions (2014-2019)
• 3.3 Global Leiomyosarcoma Drug Production, Revenue, Price and Gross Margin (2014-2019)
• 3.4 North America Leiomyosarcoma Drug Production
  • 3.4.1 North America Leiomyosarcoma Drug Production Growth Rate (2014-2019)
  • 3.4.2 North America Leiomyosarcoma Drug Production, Revenue, Price and Gross Margin (2014-2019)
• 3.5 Europe Leiomyosarcoma Drug Production
  • 3.5.1 Europe Leiomyosarcoma Drug Production Growth Rate (2014-2019)
  • 3.5.2 Europe Leiomyosarcoma Drug Production, Revenue, Price and Gross Margin (2014-2019)
• 3.6 China Leiomyosarcoma Drug Production (2014-2019)
  • 3.6.1 China Leiomyosarcoma Drug Production Growth Rate (2014-2019)
  • 3.6.2 China Leiomyosarcoma Drug Production, Revenue, Price and Gross Margin (2014-2019)
• 3.7 Japan Leiomyosarcoma Drug Production (2014-2019)
  • 3.7.1 Japan Leiomyosarcoma Drug Production Growth Rate (2014-2019)
  • 3.7.2 Japan Leiomyosarcoma Drug Production, Revenue, Price and Gross Margin (2014-2019)

4 Global Leiomyosarcoma Drug Consumption by Regions

• 4.1 Global Leiomyosarcoma Drug Consumption by Regions
• 4.2 North America Leiomyosarcoma Drug Consumption (2014-2019)
• 4.3 Europe Leiomyosarcoma Drug Consumption (2014-2019)
• 4.4 China Leiomyosarcoma Drug Consumption (2014-2019)
• 4.5 Japan Leiomyosarcoma Drug Consumption (2014-2019)

5 Global Leiomyosarcoma Drug Production, Revenue, Price Trend by Type

• 5.1 Global Leiomyosarcoma Drug Production Market Share by Type (2014-2019)
• 5.2 Global Leiomyosarcoma Drug Revenue Market Share by Type (2014-2019)
• 5.3 Global Leiomyosarcoma Drug Price by Type (2014-2019)
• 5.4 Global Leiomyosarcoma Drug Production Growth by Type (2014-2019)

6 Global Leiomyosarcoma Drug Market Analysis by Applications

• 6.1 Global Leiomyosarcoma Drug Consumption Market Share by Application (2014-2019)
• 6.2 Global Leiomyosarcoma Drug Consumption Growth Rate by Application (2014-2019)

7 Company Profiles and Key Figures in Leiomyosarcoma Drug Business

• 7.1 Advenchen Laboratories, LLC
  • 7.1.1 Advenchen Laboratories, LLC Leiomyosarcoma Drug Production Sites and Area Served
  • 7.1.2 Leiomyosarcoma Drug Product Introduction, Application and Specification
  • 7.1.3 Advenchen Laboratories, LLC Leiomyosarcoma Drug Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.1.4 Main Business and Markets Served
• 7.2 BeiGene, Ltd.
  • 7.2.1 BeiGene, Ltd. Leiomyosarcoma Drug Production Sites and Area Served
  • 7.2.2 Leiomyosarcoma Drug Product Introduction, Application and Specification
  • 7.2.3 BeiGene, Ltd. Leiomyosarcoma Drug Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.2.4 Main Business and Markets Served
• 7.3 Cell Medica Limited
  • 7.3.1 Cell Medica Limited Leiomyosarcoma Drug Production Sites and Area Served
  • 7.3.2 Leiomyosarcoma Drug Product Introduction, Application and Specification
  • 7.3.3 Cell Medica Limited Leiomyosarcoma Drug Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.3.4 Main Business and Markets Served
• 7.4 Karyopharm Therapeutics, Inc.
  • 7.4.1 Karyopharm Therapeutics, Inc. Leiomyosarcoma Drug Production Sites and Area Served
  • 7.4.2 Leiomyosarcoma Drug Product Introduction, Application and Specification
  • 7.4.3 Karyopharm Therapeutics, Inc. Leiomyosarcoma Drug Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.4.4 Main Business and Markets Served
• 7.5 Merck & Co., Inc.
  • 7.5.1 Merck & Co., Inc. Leiomyosarcoma Drug Production Sites and Area Served
  • 7.5.2 Leiomyosarcoma Drug Product Introduction, Application and Specification
  • 7.5.3 Merck & Co., Inc. Leiomyosarcoma Drug Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.5.4 Main Business and Markets Served
• 7.6 Mirati Therapeutics Inc.
  • 7.6.1 Mirati Therapeutics Inc. Leiomyosarcoma Drug Production Sites and Area Served
  • 7.6.2 Leiomyosarcoma Drug Product Introduction, Application and Specification
  • 7.6.3 Mirati Therapeutics Inc. Leiomyosarcoma Drug Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.6.4 Main Business and Markets Served
• 7.7 Novartis AG
  • 7.7.1 Novartis AG Leiomyosarcoma Drug Production Sites and Area Served
  • 7.7.2 Leiomyosarcoma Drug Product Introduction, Application and Specification
  • 7.7.3 Novartis AG Leiomyosarcoma Drug Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.7.4 Main Business and Markets Served
• 7.8 Vicore Pharma AB
  • 7.8.1 Vicore Pharma AB Leiomyosarcoma Drug Production Sites and Area Served
  • 7.8.2 Leiomyosarcoma Drug Product Introduction, Application and Specification
  • 7.8.3 Vicore Pharma AB Leiomyosarcoma Drug Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.8.4 Main Business and Markets Served

8 Leiomyosarcoma Drug Manufacturing Cost Analysis

• 8.1 Leiomyosarcoma Drug Key Raw Materials Analysis
  • 8.1.1 Key Raw Materials
  • 8.1.2 Price Trend of Key Raw Materials
  • 8.1.3 Key Suppliers of Raw Materials
• 8.2 Proportion of Manufacturing Cost Structure
• 8.3 Manufacturing Process Analysis of Leiomyosarcoma Drug
• 8.4 Leiomyosarcoma Drug Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers

• 9.1 Marketing Channel
  • 9.1.1 Direct Marketing
  • 9.1.2 Indirect Marketing
• 9.2 Leiomyosarcoma Drug Distributors List
• 9.3 Leiomyosarcoma Drug Customers

10 Market Dynamics

• 10.1 Market Trends
• 10.2 Opportunities
• 10.3 Market Drivers
• 10.4 Challenges
• 10.5 Influence Factors

11 Global Leiomyosarcoma Drug Market Forecast

• 11.1 Global Leiomyosarcoma Drug Production, Revenue Forecast
  • 11.1.1 Global Leiomyosarcoma Drug Production Growth Rate Forecast (2019-2025)
  • 11.1.2 Global Leiomyosarcoma Drug Revenue and Growth Rate Forecast (2019-2025)
  • 11.1.3 Global Leiomyosarcoma Drug Price and Trend Forecast (2019-2025)
• 11.2 Global Leiomyosarcoma Drug Production Forecast by Regions (2019-2025)
  • 11.2.1 North America Leiomyosarcoma Drug Production, Revenue Forecast (2019-2025)
  • 11.2.2 Europe Leiomyosarcoma Drug Production, Revenue Forecast (2019-2025)
  • 11.2.3 China Leiomyosarcoma Drug Production, Revenue Forecast (2019-2025)
  • 11.2.4 Japan Leiomyosarcoma Drug Production, Revenue Forecast (2019-2025)
• 11.3 Global Leiomyosarcoma Drug Consumption Forecast by Regions (2019-2025)
  • 11.3.1 North America Leiomyosarcoma Drug Consumption Forecast (2019-2025)
  • 11.3.2 Europe Leiomyosarcoma Drug Consumption Forecast (2019-2025)
  • 11.3.3 China Leiomyosarcoma Drug Consumption Forecast (2019-2025)
  • 11.3.4 Japan Leiomyosarcoma Drug Consumption Forecast (2019-2025)
• 11.4 Global Leiomyosarcoma Drug Production, Revenue and Price Forecast by Type (2019-2025)
• 11.5 Global Leiomyosarcoma Drug Consumption Forecast by Application (2019-2025)

12 Research Findings and Conclusion

13 Methodology and Data Source

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List